J. Mallon

Inhibition of diphosphonate-blocked bone mineralization. Evidence that calcitonin promotes mineralization.

A. Boris, J. Hurley, T. Trmal, 1979, Acta endocrinologica.

Effect of 1α,25-dihydroxycholecalciferol analogs on bone resorption in vitro

M. Uskoković, J. Mallon, D. Matuszewski, 1981 .

Binding specificity of the rat serum vitamin D transport protein.

J. Mallon, D. Matuszewski, H. Sheppard, 1980, Journal of steroid biochemistry.

Pharmacokinetics and biologic effects of calcitriol in normal humans.

F. Singer, J. Coburn, G. Bryce, 1985, The Journal of laboratory and clinical medicine.

An improved competitive protein binding assay for 1,25-dihydroxyvitamin D.

G. Bryce, J. G. Hamilton, O. Miller, 1980, Archives of biochemistry and biophysics.

Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic.

N. White, L. Avioli, J. Santiago, 1981, The Journal of clinical endocrinology and metabolism.

Relationship between urinary calcium and calcium intake during calcitriol administration.

F. Singer, J. Coburn, G. Bryce, 1986, Kidney international.

Effects of long‐term retinoic acid treatment on epidermal differentiation in vivo: specific modifications in the programme of terminal differentiation

R. Eichner, J. Mallon, G. J. Gendimenico, 1996, The British journal of dermatology.

Regulation of cellular retinoic acid binding protein expression in rhino mouse skin by all-trans-retinoic acid.

James T. Elder, J. Mallon, A. Åström, 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

Evidence for the promotion of bone mineralization by 1alpha,25-dihydroxycholecalciferol in the rat unrelated to the correction of deficiencies in serum calcium and phosphorus.

A. Boris, J. Hurley, T. Trmal, 1978, The Journal of nutrition.